The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor.
暂无分享,去创建一个
Eleonora Petrucci | Roberta Riccioni | U. Testa | Maurizio Cianfriglia | Ugo Testa | L. Pasquini | M. Dupuis | Maria Luisa Dupuis | M. Cianfriglia | E. Petrucci | R. Riccioni | Luca Pasquini | Manuela Bernabei | Gualtieri Mariani | M. Bernabei | Gualtieri Mariani
[1] F. Malavasi,et al. Murine monoclonal antibody recognizing a 90‐kDa cell‐surface determinant selectively lost by multi‐drug‐resistant variants of cem cells , 1990, International journal of cancer.
[2] H. Nakauchi,et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.
[3] K. Goda,et al. Effects of ATP depletion and phosphate analogues on P-glycoprotein conformation in live cells. , 2002, European journal of biochemistry.
[4] N. Ōtake,et al. Salinomycin Effects on Mitochondrial Ion Translocation and Respiration , 1976, Antimicrobial Agents and Chemotherapy.
[5] T. Tsuruo,et al. P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Esumi,et al. Salinomycin, a new polyether antibiotic. , 1974, The Journal of antibiotics.
[7] J. Raynaud,et al. Evaluation of the efficacy of salinomycin in the control of coccidiosis in chicks. , 1980, Poultry science.
[8] R. Johnstone,et al. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] 中居 永一. Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma , 2008 .
[10] M. Gottesman,et al. The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research , 2006, FEBS letters.
[11] F. Loor,et al. The abamectin derivative ivermectin is a potent P‐glycoprotein inhibitor , 1996, Anti-cancer drugs.
[12] Jos H. Beijnen,et al. P-Glycoprotein Limits Oral Availability, Brain Penetration, and Toxicity of an Anionic Drug, the Antibiotic Salinomycin , 2007, Antimicrobial Agents and Chemotherapy.
[13] Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. , 2008, Current molecular pharmacology.
[14] M. Gottesman,et al. Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.
[15] M. Mitani,et al. Salinomycin: a new monovalent cation ionophore. , 1975, Biochemical and biophysical research communications.
[16] M. Willingham,et al. Characterization by somatic cell genetics of a monoclonal antibody to the MDR1 gene product (P‐glycoprotein): Determination of p‐glycoprotein expression in multi‐drug‐resistant kb and cem cell variants , 1991, International journal of cancer.
[17] R. Johnstone,et al. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. , 1999, Blood.
[18] M. Dean. ABC Transporters, Drug Resistance, and Cancer Stem Cells , 2009, Journal of Mammary Gland Biology and Neoplasia.
[19] K. Bunting. ABC Transporters as Phenotypic Markers and Functional Regulators of Stem Cells , 2002, Stem cells.
[20] Balázs Sarkadi,et al. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). , 2008, Drug discovery today.
[21] Eric S. Lander,et al. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.
[22] Y. Jung,et al. Ionophores: their use as ruminant growth promotants and impact on food safety. , 2003, Current issues in intestinal microbiology.
[23] G. Szakács,et al. Relevance of multidrug resistance in the age of targeted therapy. , 2009, Current opinion in drug discovery & development.
[24] Michael Dean,et al. Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.
[25] R. Johnstone,et al. P-Glycoprotein Protects Leukemia Cells Against Caspase-Dependent, but not Caspase-Independent, Cell Death , 1999 .
[26] G. Opelz,et al. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. , 2009, Biochemical and biophysical research communications.
[27] I Nicoletti,et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.
[28] A. Calcabrini,et al. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells. , 2005, International journal of oncology.
[29] Z. Bacso,et al. Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies. , 2004, Biochemical and biophysical research communications.
[30] M. Willingham,et al. P‐glycoprotein epitope mapping. I. Identification of a linear human‐specific epitope in the fourth loop of the P‐glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi‐drug‐resistant cells , 2007, International journal of cancer.
[31] R. Arceci,et al. P-Glycoprotein conformational changes detected by antibody competition. , 2001, European journal of biochemistry.